Now showing items 1-2 of 2
The Study of Initiation Systems and Formulations for the Development of a Novel Silorane Biomaterial
There are approximately one million hip and knee replacements each year in the United States alone and over 70% are cemented for stabilization. The number of these replacements is expected to rise to 3.5 million per year ...
Transporter-Targeted Prodrug Delivery to Improve Oral Bioavailability of Saquinavir
Saquinavir (SQV) is the first antiretroviral protease inhibitor approved by Food and Drug Administration in the United States for the treatment of HIV infection due to its potent anti-HIV activity. However, some unfavorable ...